ATE481976T1 - Zusammensetzungen aus organischen extrakten von geum japonicum thunb var. und ihre verwendung - Google Patents

Zusammensetzungen aus organischen extrakten von geum japonicum thunb var. und ihre verwendung

Info

Publication number
ATE481976T1
ATE481976T1 AT01274733T AT01274733T ATE481976T1 AT E481976 T1 ATE481976 T1 AT E481976T1 AT 01274733 T AT01274733 T AT 01274733T AT 01274733 T AT01274733 T AT 01274733T AT E481976 T1 ATE481976 T1 AT E481976T1
Authority
AT
Austria
Prior art keywords
ischemic
compositions
japonicum thunb
organic extracts
geum japonicum
Prior art date
Application number
AT01274733T
Other languages
English (en)
Inventor
Ming Li
John Elsby Sanderson
Joseph Jao Yiu Sung
Kenneth Ka Ho Lee
Jack Chun Yiu Cheng
Edmund Ngai Man Cheung
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Application granted granted Critical
Publication of ATE481976T1 publication Critical patent/ATE481976T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01274733T 2001-11-21 2001-11-21 Zusammensetzungen aus organischen extrakten von geum japonicum thunb var. und ihre verwendung ATE481976T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/001577 WO2003043645A1 (en) 2001-11-21 2001-11-21 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof

Publications (1)

Publication Number Publication Date
ATE481976T1 true ATE481976T1 (de) 2010-10-15

Family

ID=4574892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01274733T ATE481976T1 (de) 2001-11-21 2001-11-21 Zusammensetzungen aus organischen extrakten von geum japonicum thunb var. und ihre verwendung

Country Status (11)

Country Link
US (1) US7572467B2 (de)
EP (1) EP1446134B1 (de)
JP (1) JP4982665B2 (de)
CN (1) CN1258371C (de)
AT (1) ATE481976T1 (de)
AU (1) AU2002221499B2 (de)
CA (1) CA2467895C (de)
DE (1) DE60143132D1 (de)
ES (1) ES2353378T3 (de)
PT (1) PT1446134E (de)
WO (1) WO2003043645A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049089A1 (en) * 2005-10-27 2007-05-03 Lead Billion Limited Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
WO2007049088A1 (en) * 2005-10-27 2007-05-03 Lead Billion Limited Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
US20120252744A1 (en) * 2005-10-27 2012-10-04 Lead Billion Limited Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
ES2540912T3 (es) * 2005-10-27 2015-07-14 Lead Billion Limited Composición farmacéutica y método de neoangiogénesis/revascularización útiles en el tratamiento de enfermedades cardíacas isquémicas
US12397008B2 (en) * 2006-04-13 2025-08-26 Lead Billion Limited Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
AU2010258356B2 (en) * 2009-06-12 2017-01-19 Generex Pharmaceuticals, Inc. Compositions and methods for prevention and treatment of brain diseases and conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2209222A1 (en) * 1997-06-27 1998-12-27 Keng-Yeow Sim Retrovirus protease inhibitors
US6207697B1 (en) * 1997-09-09 2001-03-27 Dupont Pharmaceuticals Company Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
JPH11236334A (ja) 1997-12-01 1999-08-31 Nissin Food Prod Co Ltd 細胞接着抑制剤
JPH11199500A (ja) * 1998-01-07 1999-07-27 Nissin Food Prod Co Ltd アトピー性皮膚炎治療剤

Also Published As

Publication number Publication date
WO2003043645A1 (en) 2003-05-30
CN1258371C (zh) 2006-06-07
EP1446134A1 (de) 2004-08-18
CA2467895A1 (en) 2003-05-30
JP4982665B2 (ja) 2012-07-25
EP1446134B1 (de) 2010-09-22
CN1558769A (zh) 2004-12-29
AU2002221499B2 (en) 2007-03-15
DE60143132D1 (de) 2010-11-04
EP1446134A4 (de) 2006-09-27
ES2353378T3 (es) 2011-03-01
CA2467895C (en) 2011-09-13
PT1446134E (pt) 2010-12-17
US20050064048A1 (en) 2005-03-24
HK1068256A1 (en) 2005-04-29
US7572467B2 (en) 2009-08-11
JP2005514360A (ja) 2005-05-19
AU2002221499A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
CL2004000639A1 (es) Compuestos derivados de quinolina y quinoxalina, composicion farmaceutica, combinacion farmaceutica; kit farmaceutico; y su uso para tratar aterosclerosis, enfermedad de arteria coronaria, enfermedad cardiaca coronaria, enfermedad vascular coronaria,
EP2450433A3 (de) Verfahren zur Herstellung und Verwendung Stammzellzusammensetzungen und Kits, die diese Zusammensetzungen umfassen
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
MX169205B (es) Composicion para estimular el crecimiento del cabello
LU91125I2 (fr) Ranélate den strontium et ses dérivés pharmaceutiquement acceptables (protelos).
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
BRPI0007481A (pt) formulação contendo cepa de bifidobacterium e uso da mesma
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
CA2299457A1 (en) Skin care composition comprising an organic extract of chick peas
DE59905484D1 (de) Pyrrolizidinalkaloidfreie petasites enthaltende zusammensetzung
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE60143132D1 (de) Zusammensetzungen aus organischen extrakten von geum japonicum thunb var. und ihre verwendung
MXPA02006511A (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido.
ATE516808T1 (de) Organisches extrakt aus der geum japonicum thunb var. und seine verwendung
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
WO2003000009A3 (en) Stimulation of vascularization with vegf-b
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
BRPI0417692A (pt) uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal
DK0967988T3 (da) Salve til behandling af forbrændinger og andre hudsygdomme
WO2002017952A3 (en) Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties